Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could a malaria pill clear discoid lupus? new trial launches

NCT ID NCT07557927

First seen May 02, 2026 · Last updated May 23, 2026 · Updated 8 times

Summary

This study tests whether dihydroartemisinin, a drug used for malaria, can safely reduce skin lesions in people with discoid lupus erythematosus (DLE). About 100 adults aged 18-65 with DLE will receive either the study drug or an active comparator for 24 weeks. The main goal is to see if the drug shrinks the area and severity of lupus skin rashes.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DISCOID LUPUS ERYTHEMATOSUS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • China-Japan Friendship Hospital

    Beijing, Beijing Municipality, China

  • Hangzhou Third People's Hospital

    Hangzhou, Zhejiang, China

  • Nanfang Hospital, Southern Medical University

    Guangzhou, Guangdong, China

  • Peking University People's Hospital

    Beijing, Beijing Municipality, China

  • Sun Yat-sen Memorial Hospital, Sun Yat-sen University

    Guangzhou, Guangdong, China

  • The First Affiliated Hospital of Anhui Medical University

    Hefei, Anhui, China

  • The First Affiliated Hospital of China Medical University

    Shenyang, Liaoning, China

  • The First Affiliated Hospital of Chongqing Medical University

    Chongqing, Chongqing Municipality, China

  • The Second Affiliated Hospital of Kunming Medical University

    Kunming, Yunnan, China

  • The Second Xiangya Hospital of Central South University

    Changsha, Hunan, China

Conditions

Explore the condition pages connected to this study.